Friday, 13. November 2009

Virtual drug tests increase patient safety: The blood simulator

Digital blood coagulation: scientists from Bayer HealthCare and Bayer Technology Services can investigate the action of drug products even without a laboratory, centrifuges or test tubes. To do this, they use a computer model that virtually simulates the processes in the blood vessels down to the smallest detail. The results make it easier to decide, for example, whether development of an active ingredient should be continued or at which dosage a new substance should be tested.

link to full article

Quicksearch Quicksearch

December 12, 2011

Published: Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, Part 2: Extension to describe performance of solid dosage forms.

» More

October 20, 2011

Published in Nature: Few inputs can reprogram biological networks

» More

October 14, 2011

Published: Quantifying stability in gene list ranking across microarray derived clinical biomarkers

» More

January 25, 2012

33rd EORTC PAMM Winter Meeting (Pharmacology and Molecular Mechanisms Group of the European Organisation for Research and Treatment of Cancer), Jan 25-28, Puerto de la Cruz, Tenerife, Spain

» More

February 08, 2012

5th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), February 8-11, Barcelona, Spain

» More

March 12, 2012

2012 ASCPT Annual Meeting, March 12-17, National Harbor, MD, USA

» More